Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ISRCTN63282459Phase 2Completed
Phase 2, randomised, open-label trial of pneumococcal 7-valent conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine in pneumococcal disease (4 arms), sponsored by Research Institute for Tropical Medicine. Primary endpoint: Antibody concentrations after alternative PCV schedules. Started May 2005; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ISRCTN63282459.